Abstract
This review presents a link between histamine and epilepsy and provides the experimental evidence available so far on the effect of histamine and histaminergic agents in various seizure models. Agents that deplete brain histamine potentiate experimental convulsions while those enhancing tend to have anticonvulsant effects. Such effects are shown to be mediated via H1 and / or H3 but not H2 receptors. Lately, a large number of selective ligands for H3-receptors have been developed. Antagonists of these receptors have shown encouraging anticonvulsant effects in animal models and hold promise for potential therapeutic applications.
Keywords: brain histamine, epilepsy, seizures, convulsions, antagonists
Current Neuropharmacology
Title: Histamine as an Anticonvulsant Inhibitory Neurotransmitter
Volume: 2 Issue: 4
Author(s): Divya Vohora, S. N. Pal and K. K. Pillai
Affiliation:
Keywords: brain histamine, epilepsy, seizures, convulsions, antagonists
Abstract: This review presents a link between histamine and epilepsy and provides the experimental evidence available so far on the effect of histamine and histaminergic agents in various seizure models. Agents that deplete brain histamine potentiate experimental convulsions while those enhancing tend to have anticonvulsant effects. Such effects are shown to be mediated via H1 and / or H3 but not H2 receptors. Lately, a large number of selective ligands for H3-receptors have been developed. Antagonists of these receptors have shown encouraging anticonvulsant effects in animal models and hold promise for potential therapeutic applications.
Export Options
About this article
Cite this article as:
Vohora Divya, Pal N. S. and Pillai K. K., Histamine as an Anticonvulsant Inhibitory Neurotransmitter, Current Neuropharmacology 2004; 2 (4) . https://dx.doi.org/10.2174/1570159043359459
DOI https://dx.doi.org/10.2174/1570159043359459 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Editorial [Hot Topic: Membrane Channels as Therapeutic Targets (Executive Editor: Jean-Claude Herve)]
Current Pharmaceutical Design Transdermal Drug Delivery: A Step towards Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology Perspectives on the Development of Antioxidant Antiepileptogenic Agents
Mini-Reviews in Medicinal Chemistry Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands
Current Topics in Medicinal Chemistry A Review on Synthesis of Benzothiazole Derivatives
Current Organocatalysis Revised Genetic Classification of Limb Girdle Muscular Dystrophies
Current Molecular Medicine Nanotechnology Driven Approaches for the Management of Parkinson’s Disease: Current Status and Future Perspectives
Current Drug Metabolism Preface
Current Drug Targets - CNS & Neurological Disorders Long-Term Outcome of Infants Born Late Preterm
Current Pediatric Reviews Preserving Brain Function During Development and Aging with Erythropoietin
Current Neurovascular Research Rufinamide Improves Functional and Behavioral Deficits <i>via</i> Blockade of Tetrodotoxin-Resistant Sodium Channels in Diabetic Neuropathy
Current Neurovascular Research Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets A New Interpretative Paradigm for Conformational Protein Diseases
Current Protein & Peptide Science Influence of CYP3A5 Polymorphism on the Pharmacokinetics of Psychiatric Drugs
Current Drug Metabolism MicroRNA-542-3p Regulates P-glycoprotein Expression in Rat Epilepsy via the Toll-like Receptor 4/Nuclear Factor-kappaB Signaling Pathway
Current Neurovascular Research The Development of Medications for Alcohol-Use Disorders Targeting the GABAB Receptor System
Recent Patents on CNS Drug Discovery (Discontinued) Knowledge of Pharmacists about Anti-epileptic Drugs in a Developing Country
Current Drug Safety Pharmacotherapy of Borderline Personality Disorder: A Systematic Review
Current Medicinal Chemistry Synthesis and Preliminary Biochemical Evaluation of Novel Derivatives of PCP
Letters in Drug Design & Discovery